Timothy E Newhook
Overview
Explore the profile of Timothy E Newhook including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
737
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serenari M, Berti D, Rivera B, Newhook T, Kristjanpoller W, Ruzzenente A, et al.
Ann Surg Oncol
. 2025 Mar;
PMID: 40050485
Background: Gallbladder cancer (GBC) has a poor prognosis, particularly in advanced stages, with surgery often offering limited survival benefit. This study aimed to identify risk factors for futile surgery (FS),...
2.
Jain A, Lendoire M, Haddad A, Tzeng C, Boyev A, Maki H, et al.
Ann Surg Oncol
. 2025 Feb;
PMID: 40000564
Background: Resection of perihilar cholangiocarcinoma (pCCA) is associated with significant perioperative morbidity and mortality. We sought to evaluate surgical outcomes following resection of pCCA over time. Methods: Patients who underwent...
3.
Maki H, Ayabe R, Haddad A, Nishioka Y, Newhook T, Tran Cao H, et al.
Ann Surg Oncol
. 2025 Feb;
PMID: 39976846
No abstract available.
4.
Seo Y, Acidi B, Newton A, Haddad A, Chiang Y, Coelho R, et al.
Cancers (Basel)
. 2025 Feb;
17(3).
PMID: 39941861
: Biliary tract cancers (BTCs) have distinct tumor biology but share a poor prognosis, with a 5-year-survival-rate of 5-19%. Surgical resection is the only potential cure, but recurrences are common....
5.
Haddad A, Khavandi M, Lendoire M, Belkacem A, Chiang Y, Gupta S, et al.
Ann Surg Oncol
. 2025 Jan;
32(4):2495-2496.
PMID: 39838241
No abstract available.
6.
Maki H, Ayabe R, Haddad A, Nishioka Y, Newhook T, Tran Cao H, et al.
Ann Surg Oncol
. 2025 Jan;
32(4):2425-2434.
PMID: 39821490
Background: The oncologic significance of specific KRAS point mutations for patients with colorectal liver metastases (CLM) is uncertain. This study aimed to assess the prognostic impact of KRAS point mutations...
7.
Fields B, Newhook T, Prakash L, Arvide E, Li Z, Tran Cao H, et al.
J Am Coll Surg
. 2025 Jan;
PMID: 39807798
Introduction: Pathway-driven, post-pancreatectomy opioid reduction interventions have proven effective and sustainable and may have a "halo effect" on other major abdominal cancer operations. This study's aim was to analyze the...
8.
9.
Haddad A, Khavandi M, Lendoire M, Acidi B, Chiang Y, Gupta S, et al.
Ann Surg Oncol
. 2024 Dec;
32(3):1752-1761.
PMID: 39633174
Background: Liver venous deprivation (LVD) is known to induce better future liver remnant (FLR) hypertrophy than portal vein embolization (PVE). The role of LVD, compared with PVE, in inducing FLR...
10.
Haddad A, Lendoire M, Uppal A, Maki H, Folkert I, Wang Y, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):1021-1032.
PMID: 39516416
Background: Carcinoembryonic antigen (CEA) levels may vary with administration and discontinuation of pre-hepatectomy chemotherapy in patients undergoing resection of colorectal cancer liver metastases (CLM). The prognostic significance of these changes,...